Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System

Table 1

Clinical data.

Parameters	Values	Description and reference
Weibull survival model of the control arm PFS	Scale = 0.04191; shape = 1.4165;	[9]
Weibull survival model of the control arm OS	Scale = 0.02143; shape = 1.18716;	[9]
HR of PFS (apatinib versus control)	0.34 (95% CI: 0.27–0.595)	[9, 10]
HR of OS (apatinib versus control)	0.57 (96% CI: 0.537–0.937)	[9, 10]